|
|
|
Insider
Information: |
Greene Barry E |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
132,162 |
|
Indirect Shares
|
6,153,503 |
|
|
Direct
Value |
$10,630,500 |
|
|
Indirect Value
|
$12,262,113 |
|
|
Total
Shares |
6,285,665 |
|
|
Total
Value |
$22,892,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
President |
2020-09-09 |
70,343 |
2020-09-09 |
3,003 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
Karyopharm Therapeutics Inc. |
KPTI |
Director |
2022-08-11 |
13,606 |
2015-04-02 |
0 |
Premium* |
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-05-21 |
1,273 |
2017-01-03 |
0 |
Premium* |
|
Sage Therapeutics, Inc. |
SAGE |
|
2022-11-10 |
46,940 |
2021-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-02-09 |
4 |
OE |
$22.13 |
$16,000 |
D/D |
723 |
723 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-02-09 |
4 |
AS |
$22.65 |
$16,376 |
D/D |
(723) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2012-02-21 |
4 |
B |
$10.75 |
$19,995 |
D/D |
1,860 |
4,572 |
2.74 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2013-05-28 |
4 |
OE |
$0.95 |
$21,681 |
D/D |
22,822 |
19,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2013-03-08 |
4 |
OE |
$0.95 |
$22,800 |
D/D |
24,000 |
28,572 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & COO |
|
2013-03-14 |
4 |
OE |
$0.95 |
$22,855 |
D/D |
24,058 |
28,630 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2008-08-13 |
4 |
OE |
$0.95 |
$29,345 |
D/D |
30,889 |
30,889 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-01-03 |
4 |
OE |
$15.91 |
$48,000 |
D/D |
3,017 |
3,017 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-01-03 |
4 |
AS |
$19.26 |
$58,113 |
D/D |
(3,017) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2014-11-11 |
4 |
OE |
$6.78 |
$75,258 |
D/D |
11,100 |
44,692 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2013-12-17 |
4 |
OE |
$6.78 |
$75,936 |
D/D |
11,200 |
15,772 |
0 |
- |
|
KPTI |
Karyopharm Therapeutics I... |
Director |
|
2015-04-02 |
4 |
B |
$29.31 |
$87,938 |
D/D |
3,000 |
3,000 |
2.39 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2014-02-03 |
4 |
D |
$78.68 |
$132,182 |
D/D |
(1,680) |
33,592 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2014-02-03 |
4 |
OE |
$6.78 |
$132,210 |
D/D |
19,500 |
35,272 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2016-03-24 |
4 |
OE |
$7.10 |
$135,672 |
D/D |
16,540 |
64,804 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2017-09-21 |
4 |
OE |
$7.10 |
$146,042 |
D/D |
11,844 |
100,428 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
COO |
|
2007-10-24 |
4 |
AS |
$31.36 |
$165,126 |
D/D |
(5,220) |
4,551 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2020-04-07 |
4 |
D |
$104.75 |
$174,321 |
D/D |
(1,663) |
62,236 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-08-01 |
4 |
OE |
$18.21 |
$182,100 |
D/D |
10,000 |
10,000 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2018-05-21 |
4 |
D |
$23.10 |
$201,594 |
D/D |
(8,727) |
1,273 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2018-05-21 |
4 |
OE |
$20.16 |
$201,600 |
D/D |
10,000 |
10,000 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2020-05-06 |
4 |
OE |
$9.14 |
$203,502 |
D/D |
22,265 |
84,501 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President |
|
2020-07-07 |
4 |
OE |
$9.14 |
$203,502 |
D/D |
22,265 |
84,501 |
0 |
- |
|
ACOR |
Acorda Therapeutics Inc |
Director |
|
2017-08-01 |
4 |
AS |
$21.57 |
$215,697 |
D/D |
(10,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
President and COO |
|
2014-11-17 |
4 |
OE |
$6.78 |
$225,096 |
D/D |
33,200 |
66,792 |
0 |
- |
|
80 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|